This inventor holds 1 USPTO granted patent. Top assignee: Innophos, Inc.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Albert Lebugle - Innovator in Nanometric Calcium Phosphate Platelets
Introduction
Albert Lebugle is an innovative inventor based in Saint Orens de Gameville, France. He has made significant contributions to the field of materials science, particularly through his work on nanometric calcium phosphate platelets. His inventiveness is showcased by a patented invention that addresses various applications across multiple industries.
Latest Patents
Albert Lebugle holds a patent for the production of nanometric calcium phosphate platelets. The patent describes these platelets, which range in length from 250 nm to 800 nm, and outlines methods for their production. The innovation enables the use of these platelets in the creation of suspensions or colloidal dispersions when combined with a dispersing agent. The diverse applications of his invention include reinforcing fillers, polishing agents, building materials, additives for oral formulations, dentifrices, and encapsulating agents.
Career Highlights
Lebugle is currently associated with Innophos, Inc., where he continues to contribute to innovative research and development. His role at Innophos marks a significant point in his career, allowing him to focus on advanced material solutions that cater to various industrial needs.
Collaborations
Albert works alongside esteemed colleagues such as Jean-Yves Chane-Ching. This collaboration enhances the research output and innovation capacity within their projects, particularly in the realm of materials science and applications of calcium phosphate.
Conclusion
In summary, Albert Lebugle stands out as an inventive force in the development of nanometric calcium phosphate platelets. His patented invention has far-reaching implications for several industries, reflecting his expertise and dedication to advancing material technologies. With his continued work at Innophos, Lebugle is poised to make further significant contributions to the field.